Percutaneous Transcatheter Valve-in-Valve Pulmonary and Tricuspid Replacement in Carcinoid Heart Disease
- PMID: 34317287
- PMCID: PMC8298683
- DOI: 10.1016/j.jaccas.2019.11.089
Percutaneous Transcatheter Valve-in-Valve Pulmonary and Tricuspid Replacement in Carcinoid Heart Disease
Abstract
Surgical valve replacement is the most effective treatment for carcinoid heart disease; however, reoperation for prosthetic valve failure is burdened by high risk. We report the first described percutaneous transcatheter pulmonary and tricuspid valve-in-valve replacement for bioprosthesis degeneration for any reason in a patient with carcinoid heart disease. (Level of Difficulty: Advanced.).
Keywords: ViV, transcatheter valve-in-valve; carcinoid heart disease; prosthetic degeneration; transcatheter valve in valve.
© 2020 The Authors.
Figures
References
-
- Larsen S.H., Dimopoulos K., Gatzoulis M.A. Surgical and percutaneous pulmonary valve replacement in England over the past two decades. Heart. 2019;105:932–937. - PubMed
-
- Färber G., Tkebuchava S., Dawson R.S. Minimally invasive, isolated tricuspid valve redo surgery: a safety and outcome analysis. Thorac Cardiovasc Surg. 2018;66:564–571. - PubMed
-
- Rodés-Cabau J., Hahn R.T., Latib A. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol. 2016;67:1829–1845. - PubMed
-
- Eicken A., Schubert S., Hager A. Percutaneous tricuspid valve implantation: two-center experience with midterm results. Circ Cardiovasc Interv. 2015;8 - PubMed
-
- Luthra S., Westaby S., Ormerod O., Wilson N., Forfar C. Transventricular pulmonary valve implantation in corrected truncus arteriosus. Ann Thorac Surg. 2012;93:660–661. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
